Back to Authors

Woest, Manon E.

Mayo Clinic

University of Groningen

Citations 3

A110-20 Osteoglycin Fragment Suppresses Fibroblast Activation and Promotes Lung Tissue Repair
Gosens, R, Woest, M, Elferink, R, Ngassie, M Koloko, Prakash, Y, Timens, W, Burgess, J K, Brandsma, C -A, Nagelkerke, A, Frijlink, E, Koog, L Van Der, Gosens, Reinoud , Woest, Manon E., Elferink, Robin A B, Ngassie, Maunick Lefin Koloko , Prakash, Y, Burgess, Janette K. , Brandsma, Corry‐Anke , Nagelkerke, Anika , Koog, Luke van der

American Journal of Respiratory and Critical Care Medicine | June 22, 2026 | Volume: 212 | Issue: Supplement_2 | Pages: No page available

10.1093/ajrccm/aamag286.174 Get It

Abstract Introduction Pulmonary fibrosis is characterized by excessive fibroblast activation and alveolar remodeling, leading to progressive lung dysfunction. Osteoglycin (OGN), a small leucine-rich proteoglycan, and its functional fragment MC002 have been identified as regulators of alveolar epithelial regeneration, a process that is impaired in fibrotic lung disease. This study investigates the effects of OGN and MC002 on TGF-β-induced fibrotic responses in lung fibroblasts, organoids, and an in vivo fibrosis model. Methods Human lung fibroblasts (MRC5) were treated with OGN or MC002 for 48 hours, with or without transforming growth factor-beta (TGF-β; 2 ng/mL). Expression of the myofibroblast marker α-smooth muscle actin (ACTA2) and matrix markers collagen 1a1 (COL1A1) and fibronectin (FN1) was assessed by RT-PCR and Western blotting. Global transcriptomic changes were analyzed by RNA sequencing. Myofibroblast differentiation was evaluated by phalloidin staining and quantified using the phalloidin/DAPI ratio. Murine lung organoids were generated by co-culturing epithelial progenitor cells with fibroblasts and treated with TGF-β (2 ng/mL) in the presence or absence of OGN or MC002. Organoid number, size, and alveolar differentiation were quantified after 14 days. In vivo, pulmonary fibrosis was induced in mice using intratracheal bleomycin. MC002 was administered at different doses (6.75 µg or 20.25 µg) every other day starting from day 7 post-bleomycin, and lung weight and pressure-volume (PV) loops were assessed to evaluate fibrotic burden and lung mechanics. Osteoglycin expression in human lung tissue from 13 non-smokers, 11 ex-smokers, and 12 IPF patients was analyzed by immunostaining. Results TGF-β induced pro-fibrotic gene expression in fibroblasts, while OGN and MC002 alone had no pro-fibrotic effects. MC002 fully reversed TGF-β-induced ACTA2, COL1A1, and FN1 expression, whereas OGN selectively attenuated COL1A1. RNA-sequencing revealed broad suppression of fibrosis- and ECM-associated gene programs by MC002. At the protein level, TGF-β-induced ACTA2 expression was reversed by MC002 but not by OGN. Both compounds reduced TGF-β-induced stress fiber formation. In lung organoids, TGF-β impaired organoid formation and alveolar differentiation, effects that were restored by OGN and MC002 in a concentration-dependent manner. In the bleomycin model, MC002 significantly reduced lung weight and improved PV loop profiles, indicating attenuation of fibrotic stiffening and improved lung compliance. Osteoglycin protein expression was significantly diminished in IPF whole lung tissue and parenchyma compared to controls. Conclusion OGN, and particularly MC002, counteract TGF-β-driven fibroblast activation and myofibroblast differentiation while promoting alveolar preservation. The superior efficacy of MC002 supports its potential as a therapeutic candidate for pulmonary fibrosis. This abstract is funded by: Lung Foundation Netherlands 10.1.23.021PPS
Mimecan and a Functional Fragment Hereof as a Novel Regenerative Agent for COPD
Woest, Manon E., Gorter, I.C., Dhakad, Deepesh, Koog, Luke van der , Ngassie, Maunick Lefin Koloko , Prakash, Y. S. , Brandsma, Corry‐Anke , Yildirim, Ali Önder , Frijlink, Henderik Willem , Nagelkerke, Anika , Gosens, Reinoud

A18. FIXING WHAT'S BROKEN: NOVEL THERAPEUTICS FOR LUNG REMODELING | April 30, 2024 | Volume: No volume available | Issue: No issue available | Pages: A1050-A1050

10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a1050 Get It

Cholinergic neuroplasticity in asthma driven by TrkB signaling
Dragunas, Guilherme , Woest, Manon E., Nijboer, Susan, Bos, Sophie, Asselt, Janet, Groot, Anne P. de , Vohlídalová, Eva, Vermeulen, Corneel J., Ditz, Benedikt , Koppelman, Gerard H. , Berge, Maarten van den , Hacken, Nick H.T. ten , Timens, Wim , Munhoz, Carolina Demarchi , Prakash, Y. S. , Gosens, Reinoud , Kistemaker, Loes , Prakash, Y S , Gosens, Reinoud , Timens, Wim , Vermeulen, Cornelis Joseph , Vonk, Judith M.

The FASEB Journal | April 11, 2020 | Volume: 34 | Issue: 6 | Pages: 7703-7717

10.1096/fj.202000170r Get It

Abstract Parasympathetic neurons in the airways control bronchomotor tone. Increased activity of cholinergic neurons are mediators of airway hyperresponsiveness (AHR) in asthma, however, mechanisms are not elucidated. We describe remodeling of the cholinergic neuronal network in asthmatic airways driven by brain‐derived neurotrophic factor (BDNF) and Tropomyosin receptor kinase B ( TrkB). Human bronchial biopsies were stained for cholinergic marker vesicular acetylcholine transporter (VAChT). Human lung gene expression and single nucleotide polymorphisms (SNP) in neuroplasticity‐related genes were compared between asthma and healthy patients. Wild‐type (WT) and mutated TrkB knock‐in mice (Ntrk2tm1Ddg/J) with impaired BDNF signaling were chronically exposed to ovalbumin (OVA). Neuronal VAChT staining and airway narrowing in response to electrical field stimulation in precision cut lung slices (PCLS) were assessed. Increased cholinergic fibers in asthmatic airway biopsies was found, paralleled by increased TrkB gene expression in human lung tissue, and SNPs in the NTRK2 [TrkB] and BDNF genes linked to asthma. Chronic allergen exposure in mice resulted in increased density of cholinergic nerves, which was prevented by inhibiting TrkB. Increased nerve density resulted in AHR in vivo and in increased nerve‐dependent airway reactivity in lung slices mediated via TrkB. These findings show cholinergic neuroplasticity in asthma driven by TrkB signaling and suggest that the BDNF‐TrkB pathway may be a potential target.